Background Chronic non-communicable diseases, including hypertension, have become major threats to urban public health. The built environment has been linked to blood pressure. Objective To examine joint exposure patterns of built environment factors in relation to residents' blood pressure status and to identify environmental profiles of neighborhoods that may be favorable or unfavorable to hypertension prevention. Methods (1) A cross-sectional study was conducted among 1910 residents in Longzihu District, Bengbu City. Demographic characteristics, clinical indicators (including blood pressure), and lifestyle behavioral data were collected. Nine built environment indicators were derived within a 500-meter buffer zone surrounding each participant's residential address. (2) Using elevated blood pressure status as a binary outcome (all residents) and grade of elevated blood pressure as an ordinal multi-class outcome (residents with elevated blood pressure), the predictive performance of four binary classification models and nine multi-class classification models was compared, respectively. Feature importance was ranked based on the best-performing model. Multi-variable logistic regression with stepwise adjustment was then used to identify key environmental factors. (3) Using partial dependence plots, a joint exposure analysis was conducted in the target population of residents with elevated blood pressure (high-normal blood pressure and hypertension grades 1–3), with the 25th and 75th percentiles of key environmental factors as the low- and high-level thresholds, respectively. The 95% confidence intervals were estimated using the Bootstrap method. Results (1) Among the study participants, 863 had elevated blood pressure: 349 (40.4%) had high-normal blood pressure, and 398 (46.1%), 93 (10.8%), and 23 (2.7%) had hypertension grades 1, 2, and 3, respectively. (2) Logistic regression showed the best performance in analyzing the association between built environment factors and elevated blood pressure status (n=1910), whereas random forest showed the best performance in analyzing the association between built environment factors and grade of elevated blood pressure (n=863). Road density, bus stop density, and hospital/clinic density were key environmental factors. (3) Pairwise joint exposure patterns were observed among the three key environmental factors: When any two were both below the low-level thresholds (road ≤0.54 km·km⁻², bus stop ≤0.51 points·km⁻², hospital ≤5.99 points·km⁻²), the risk of a higher grade of elevated blood pressure was greater than the overall sample average (relative predicted odds 1.29–1.31, 95% confidence interval lower bound >1); when any two were both above the high-level thresholds (road ≥0.75 km·km⁻², bus stop ≥1.25 points·km⁻², hospital ≥15.00 points·km⁻²), the risk was lower than the overall sample average (relative predicted odds 0.54–0.61, 95% confidence interval upper bound <1); low-high and high-low combinations did not differ significantly from the overall sample average (P > 0.05). Conclusion Joint exposure profiles characterized by road density, bus stop density, and hospital/clinic density are associated with elevated blood pressure among residents: Simultaneously low levels of any two of these environmental indicators are associated with a higher predicted risk of a more severe grade, whereas simultaneously high levels are associated with a lower predicted risk. These findings suggest that coordinated configurations of road networks, public transit accessibility, and medical service facilities may represent important environmental feature of neighborhoods favorable to hypertension prevention and control.

The concept of precision oncology and the development of novel anti-cancer drugs have driven the progress of tumor molecular diagnosis. Breakthroughs in new technologies, such as next-generation sequencing and liquid biopsy, have opened a new page for tumor molecular diagnosis. The clinical applications of molecular diagnosis have completely covered the whole process of tumor diagnosis and treatment. However, the clinical implementation of these new technologies clinically still face to challenges. In the future, the field of tumor molecular diagnosis will focus more on the rational and compliant application of new technologies, as well as taking full advantages of artificial intelligence and decision support tools, to elevate clinical application value of molecular diagnosis, and consequently to drive further development of precision oncology.

Objective:To evaluate the accuracy and feasibility of an automated scanning and uptake system to assist pathologists with hu-man epidermal growth factor receptor 2(HER2)FISH interpretation.Methods:HER2 gene amplification is detected using FISH,and"result interpretation by independent pathologists"is regarded as the"gold standard."The consistency of"human-machine dialogue results"(use of a CytoVision* system combined with manual interpretation)and"CytoVision*-based automated interpretation"with the"gold standard"was assessed.Results:Consistency between"human-machine dialogue results"and the"gold standard"can surpass 91%,with the former method saving up to 50%of the manual operation time.The tendency of each cell nucleus's HER2 copy number to be"underestimated"is the main reason for the low sensitivity observed in cases with low copy number amplification and HER2 heterogeneous expression cases in"human-machine dialogue interpretation."Conclusions:Automatic FISH image analysis and uptake systems simulate the process of manu-ally interpreted cell selection,ensure random cell selection,and improve work efficiency.With its accurate selection of the hybridization re-gion and"human-computer dialogue,"the system is expected to"replace"interpretation by independent pathologists.

Objective To analyze the changes and clinical significance of aqueous humor stromal cell-de-rived factor-1(SDF-1),macrophage chemoattractant protein-1(MCP-1)and soluble adhesion molecule CD44(sCD44)in patients with diabetic cataract(DC).Methods A total of 80 patients with DC admitted to the hos-pital from January 2021 to January 2023 were selected as the DC group,and 40 patients with simple cataract during the same period were selected as the age-related cataract group.According to the stage of cataract,DC patients were divided into group A(incipient stage,32 cases),group B(intumescent stage,26 cases)and group C(mature stage and over mature stage,22 cases).According to the presence or absence of macular ede-ma after treatment,the patients were divided into occurrence group(20 cases)and non-occurrence group(60 cases).The levels of SDF-1,MCP-1 and sCD44 in each group were detected by enzyme-linked immunosorbent assay.The receiver operating characteristic curve and area under the curve(AUC)were used to analyze the value of SDF-1,MCP-1 and sCD44 levels in the diagnosis of DC.Results The levels of SDF-1,MCP-1 and sCD44 in the DC group were higher than those in the age-related cataract group(P<0.05),and the levels of SDF-1,MCP-1 and sCD44 in the A,B and C groups increased sequentially(P<0.05).The level of MCP-1 in the occurrence group was higher than that in the non-occurrence group(P<0.05).The AUC of MCP-1,sCD44 and SDF-1 in the diagnosis of DC was 0.869,and the diagnostic efficiency was better.Conclusion The changes of aqueous SDF-1,MCP-1 and sCD44 levels are related to the stage of cataract in DC patients.Dynam-ic monitoring of these three indexes,especially MCP-1,is helpful to judge the condition and prognosis of DC patients.

The concept of precision oncology and the development of novel anti-cancer drugs have driven the progress of tumor molecular diagnosis. Breakthroughs in new technologies, such as next-generation sequencing and liquid biopsy, have opened a new page for tumor molecular diagnosis. The clinical applications of molecular diagnosis have completely covered the whole process of tumor diagnosis and treatment. However, the clinical implementation of these new technologies clinically still face to challenges. In the future, the field of tumor molecular diagnosis will focus more on the rational and compliant application of new technologies, as well as taking full advantages of artificial intelligence and decision support tools, to elevate clinical application value of molecular diagnosis, and consequently to drive further development of precision oncology.

Objective:To analyze the relationship between clinicopathological features and germline mismatch repair (MMR) gene variants in endometrial cancer patients and to evaluate the clinical utility of germline multi-gene panel testing.Methods:This single-center, retrospective case series study included 100 endometrial cancer patients treated in Zhongshan Hospital, Fudan University between July 2022 and February 2024. We collected clinicopathological data and tumor molecular testing results. 61 cancer susceptibility genes were tested using next-generation sequencing, and the associations between the detection rate of germline variants and the clinicopathological characteristics in endometrial cancer patients were explored.Results:Among 100 patients, 28% (28/100) were found to have pathogenic variants in cancer susceptibility genes, of which 20 patients carried germline MMR gene variants and the remaining 8 patients carried variants in other cancer susceptibility genes. Of the 20 patients diagnosed with Lynch syndrome, only 40% (8/20) met the Chinese family history criteria for Lynch syndrome. Among 53 patients with intact MMR protein expression, 1 patient was identified with a germline MMR gene variant. In the 14 Lynch syndrome patients with confirmed microsatellite status, 5/14 of those showed low microsatellite instability or microsatellite stability. Germline multi-gene panel testing in all endometrial cancer patients additionally identified 1 Lynch syndrome patient and 8 patients with non-Lynch hereditary cancers.Conclusion:Current clinical screening criteria may miss some endometrial cancer patients with Lynch syndrome. Compared with traditional screening pattern, germline multi-gene panel testing not only improves the detection rate of Lynch syndrome in endometrial cancer patients but also identifies other hereditary cancer predispositions.

Objective:To evaluate the accuracy and feasibility of an automated scanning and uptake system to assist pathologists with hu-man epidermal growth factor receptor 2(HER2)FISH interpretation.Methods:HER2 gene amplification is detected using FISH,and"result interpretation by independent pathologists"is regarded as the"gold standard."The consistency of"human-machine dialogue results"(use of a CytoVision* system combined with manual interpretation)and"CytoVision*-based automated interpretation"with the"gold standard"was assessed.Results:Consistency between"human-machine dialogue results"and the"gold standard"can surpass 91%,with the former method saving up to 50%of the manual operation time.The tendency of each cell nucleus's HER2 copy number to be"underestimated"is the main reason for the low sensitivity observed in cases with low copy number amplification and HER2 heterogeneous expression cases in"human-machine dialogue interpretation."Conclusions:Automatic FISH image analysis and uptake systems simulate the process of manu-ally interpreted cell selection,ensure random cell selection,and improve work efficiency.With its accurate selection of the hybridization re-gion and"human-computer dialogue,"the system is expected to"replace"interpretation by independent pathologists.

Endoplasmic reticulum stress(ERS)plays a crucial role in cellular self-protection.In response to environmental changes,cells activate the unfolded protein response(UPR)and endoplasmic reticulum-associated protein degradation pathways to restore homeostasis.Increasing experimental evidence indicates that hypoxia and inflammation negatively impact synoviocytes in rheumatoid arthritis(RA),leading to the activation of three key endoplasmic reticulum transmembrane proteins:inositol-requiring enzyme 1,protein kinase R-like endoplasmic reticulum kinase,and activating transcription factor 6.These proteins mediate UPR pathways that are implicated in the pathological progression of RA.Targeting ERS-related molecules has emerged as a promising therapeutic strategy for RA.This article reviews the impact of ERS on the pathogenesis of RA and discusses drugs that modulate ERS as potential treatments for the disease.

Objective To understand the detection rate of children with phenylketonuria(PKU)in southern Xinjiang in recent 10 years,and analyze the mutation of phenylalanine hydroxylase(PAH)gene in children with classical PKU in southern Xinjiang,so as to provide effective reference for clinical treatment.Methods The concentration of phenylalanine(PHE)in dried filter paper blood was de-tected by chemical fluorescence method for PKU screening of live births in southern Xinjiang.The heel blood or venous blood of 29 Uygur PKU children diagnosed in southern Xinjiang were collected.The exons 10,11,12 of PAH gene and the intron junction region of Uygur PKU children were sequenced by polymerase chain reaction(PCR)product direct sequencing method to determine the mutation site.Results A total of 5gene mutation types and 13mutation sites were detected in 58 chromosomes,and the mutation detection rate was 44.83％(13/29).The five mutations were divided into two mutation sites of ivs10-1(c.1066-11g＞a)in the junction region be-tween exon 10 and intron,and four P L3851(c.1155g＞c)mutation site,4 exon 12 P R413p(c.1238g＞c)mutation site,1 exon 12 P T418p(c.1252a＞c)mutation site,two ivs12+1(c.1315+1g＞a)mutation sites in exon 12;Two site mutations were detected in 2 of 29 children.Conclusion The detection rate of PKU in southern Xinjiang in recent 10 years was retrospectively analyzed.The mutation types and characteristics of exons 10,11 and 12 of PAH gene and the intron junction region of PAH gene in Xinjiang Uygur children with phenylketonuria were clarified,which laid the foundation for further study of phenylketonuria in Uygur families.

It is believed that patients with cirrhotic ascites exhibit a pathological mechanism characterized by the decline of healthy qi and the accumulation of pathogenic factors. Clinically， treatment should be based on the theory of tonification and purging， with a staged approach distinguishing between the active phase and the remission phase. The balance between tonification and purging should be adjusted according to the progression of pathogenic and healthy actors. In the acute phase， purging should take precedence over tonification， using purging as a means of tonification to facilitate the flow of water and qi through the triple energizer. The severity of water retention， dampness， blood stasis， and heat should be carefully assessed to ensure thorough elimination of pathogenic factors while avoiding harm to healthy qi. Medication adjustments should be made once the pathogenic factors are significantly weakened. In the remission phase， an integrated approach combining both tonification and purging should be adopted， incorporating purging within tonification to clear residual pathogens and prevent recurrence. Concurrently， proactive treatment of the underlying disease is essential to achieve complete recovery and prevent the recurrence of ascites.